10d
First for Women on MSNLa La Anthony on Her Plaque Psoriasis: ‘It Doesn't Have To Hold You Back'Since revealing her plaque psoriasis diagnosis in 2015, La La Anthony has become a powerful voice for those living with the ...
While I have had a few bouts of TSW, which has resulted in new inflammation in previously unaffected areas, I was able to get my psoriasis back to a place that had little impact on my day-to-day life.
Between 45-56% of people living with psoriasis may experience these symptoms affecting the scalp, hairline, forehead, back of the neck and around the ears. Treatment includes use of over-the ...
Opens in a new tab or window Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread adoption. This analysis involving patients in the ...
Stress is a common trigger for psoriasis, and with so much uncertainty happening, my flare-ups came right back." This time around, though, Rimes has decided not to hide. She first revealed in 2008 ...
Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...
Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a ...
Genital psoriasis is a subset of psoriasis. Genital psoriasis does not affect the mucous membranes, so sexual function should not be impaired. It's the plaques on the surrounding skin that can ...
J&J's head of immunodermatology Liza O'Dowd said that the "robust results" with its oral IL-23 drug have the potential to ...
Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, ...
Opens in a new tab or window Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed ...
Bristol Myers Squibb has released new 5-year results from the long-term trial evaluating Sotyktu for the treatment of adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results